ALPS.US Alps Group Inc

12.46 USD
Close of Nov 14, 2026
1.01 8.60
Market cap
USD 37.4M
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Is ALPS.US undervalued?

Graham number

The Graham number of Alps Group Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Alps Group Inc fundamental analysis

No fundamental analysis for Alps Group Inc yet.

Alps Group Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Alps Group Inc

Alps Group, Inc. operates as a biotechnology company that integrates research and development, medical services, and wellness solutions. The company focuses on creating a fair healthcare ecosystem, to make advance predictive, preventive, and precision medicine accessible and affordable. The company is headquartered in Kuala Lumpur, Malaysia.

Full company profile